DendrisChipRD is now CE IVD
Dendris was present from to the 29th ECCMID in Amsterdam (13-16 April 2019)
Dendris has published in DIAGNOSTICS
"Innovative DendrisChips® Technology for a Syndromic Approach of In Vitro Diagnosis: Application to the Respiratory Infectious Diseases" See publication
Dendris has published in SCIENCE CHINA Materials
"Multiplexing technology for in vitro diagnosis of pathogens: the key contribution of phosphorus dendrimers” by Jean Pierre Majoral View publication
Two new partner laboratories join Dendris in 2018
Since February 2018, Dendris has tested its device on two news partner pilot site, Gen-Bio Gravanches, in Clermont Ferrand and Biolab avenir in Toulouse.
Dendris will be present at Ricai on december 2018 17th and 18th
RICAI is a well known congress dedicated to infectious diseases. Dendris will present its molecular diagnosis devices on december 2018 17th and 18th at the palais des congress in Paris. http://www.ricai.fr
Happy new year !
Dendris team wishes you a happy new year 2018 !
Dendris at RICAI event December 2017 at Paris
RICAI is a well known congress dedicated to infectious diseases. Dendris presented its molecular diagnosis devices. We presented a poster titled : "Diagnostic syndromique des infections respiratoires" Alice Senescau-Lemoine, Tatiana Kemposky-Hamon, Elodie Bernard,...
Certified quality system
Dendris has obtained quality management system certificate ISO 13485:2016 in November 2017 for design, development, manufacturing and distribution of in-vitro diagnostic test kits used in the diagnosis of respiratory infections.
Dendris continues its momentum by installing pilot sites
During the year 2017, Dendris tested its device on two partner pilot sites. A third site is planned for installation in February 2018 as well as two other current 2018